Administration of dendritic cells partially matured in vitro for the treatment of tumors

Details for Australian Patent Application No. 2003293411 (hide)

Owner Northwest Biotherapeutics, Inc.

Inventors Bosch, Marnix L.

Agent Spruson & Ferguson

Pub. Number AU-B-2003293411

PCT Number PCT/US2003/0386

PCT Pub. Number WO2004/053072

Priority 60/431,267 06.12.02 US

Filing date 5 December 2003

Wipo publication date 30 June 2004

Acceptance publication date 28 October 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/431,267 06.12.02 US

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2003293411

28 October 2010 Application Accepted

  Published as AU-B-2003293411

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003293412-HIGH EFFICACY ANTISENSE RiAlpha PKA POLY-DNP OLIGORIBONUCLEOTIDES

2003293410-METHOD AND APPARATUS FOR ADAPTIVE CLIENT COMMUNICATIONS